Omnicell, Inc. · NASDAQ:OMCL
Omnicell — 41st Annual J.P. Morgan Healthcare Conference 2023
10 slides from Omnicell's conference presentation, Jan 11, 2023
Slide 1: J.P. Morgan 2023 Healthcare Conference
os) Omnicell J.P. Morgan 2023 a Healthcare Conference January 11, 2023
Slide 2: Forward-Looking Statements
Forward-Looking Statements 30 YEARS This presentation contains “forward-looking statements” within the meaning of federal securities laws. These forward-looking statements include statements with respect to strategic and growth opportunities, other expectations and other non-historical information.
Slide 3: Our Mission
YEARS Our Mission Be the clinician’s most trusted partner for medication management. We are dedicated to continuously deliver innovative technology that helps our customers improve patient care, for everyone. Our Vision Deliver the most compelling automation and services that accelerate pharmacy per
Slide 4: Omnicell is uniquely positioned...
Omnnicell is uniquely J positioned... YY in WD.
Slide 5: Leader in Large and Growing Segments
Leader in Large and Growing Segments Omnicell is growing its leadership position across a potential $90B+ Total Addressable Market (TAM) NS Estimated TAM Opportunity! e o $22B $19B Retail Point of Care $90B+ TOTAL TAM e o@ $19B $32B Specialty Pharmacy Services Central Pharmacy
Slide 6: Omnicell — Across the Continuum of Care
Omnnicell — Across the Continuum of Care 2 Omnicell has 30 years of experience within medication management across the entire continuum of care RA a AtriumHealth UPMC texas chidren's MercyT Hospital” \NYULangone BON SECOURS MERCY HEALTH Health Costco ~50% iD Mass G i (0) 1! Mass General Brigham tall
Slide 7: Central Pharmacy Dispensing Service / Inventory Optimization Service
ds = Central Pharmacy Dispensing Service Inventory Qptimization Service \V Compounding Service s Specialty Pharmacy Services (o) Omnicell’ <5 Point of Care Connected EnlivenHealth Intelligent Infrastructure Inpatient Outpatient
Slide 8: Significant Potential Growth Opportunity
Significant Potential Growth Opportunity Growing and expanding within large existing customer base (sites & platform solutions) Continuing market share gains 30 Executing value-enhancing M&A, which can present significant cross-selling opportunities
Slide 9: Omnicell is Positioned to Win
Omnnicell is Positioned to Win Omnicell has the right solutions and the right business model to solve the medication management problem that the healthcare system is facing Omnicell is positioned as the leading strategic partner to health systems in large and growing market segments with $90B+ TAM!
Slide 10: 30 Years of Innovation
YEARS of INNOVATION
Omnicell — 41st Annual J.P. Morgan Healthcare Conference 2023 on 6ix